Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05576467 · ClinicalTrials.gov registry record · NA

Treatment for Migraine and Mood

A NA study of Migraine and Depressive Symptoms, sponsored by Amanda Shallcross.

Active
Registry status
NA
Development phase
145
Enrollment target
3
Study locations

NCT05576467 is a NA study of Migraine and Depressive Symptoms that is active but no longer recruiting, run by Amanda Shallcross. The registered enrollment target is 145 participants, below the 357-participant average among 102 other Migraine trials with a reported enrollment target (59% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05576467, a NA study of Migraine and Depressive Symptoms, is active but no longer recruiting, sponsored by Amanda Shallcross.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
145 participants
Enrollment target
3
Study locations

Study Summary

The researchers propose a three-arm pilot study of Mindfulness-Based Cognitive Therapy (MBCT) delivered via telephone (MBCT-T), video (MBCT-V) or Enhanced Usual Care (EUC).

Interventions

  • BEHAVIORAL Enhanced Usual Care (EUC)
  • BEHAVIORAL MBCT-Telephone
  • BEHAVIORAL MBCT-Video

Study Locations (3)

New York

  • Albert Einstein College of Medicine - The Bronx

North Carolina

  • Wake Forest University School of Medicine - Winston-Salem

Ohio

  • The Cleveland Clinic - Cleveland

Trial Details

FieldValue
Enrollment Target 145 participants
Start Date 2024-03-17
Est. Completion 2026-10-20
Phase NA

Sponsor

Amanda Shallcross

2 total trials

What the Registry Record Tells You About NCT05576467

The ClinicalTrials.gov registry entry for NCT05576467 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 145 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 357-participant average among 102 other Migraine trials with a reported enrollment target (59% lower). The listed sponsor is Amanda Shallcross, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Migraine appearing as the primary indexed condition, and to 3 interventions - of which Enhanced Usual Care (EUC) is the first listed.

NCT05576467 reports 3 study locations spanning 3 distinct geographic areas - top geographies include New York, North Carolina, Ohio.

Frequently Asked Questions

What is clinical trial NCT05576467 about?

NCT05576467 is a clinical study titled "Treatment for Migraine and Mood". The researchers propose a three-arm pilot study of Mindfulness-Based Cognitive Therapy (MBCT) delivered via telephone (MBCT-T), video (MBCT-V) or Enhanced Usual Care (EUC).

What is the current status of trial NCT05576467?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 145 participants. The study started on 2024-03-17. Estimated completion is 2026-10-20.

What conditions does trial NCT05576467 study?

This clinical trial studies the following conditions: Migraine, Depressive Symptoms.

What interventions are being tested in trial NCT05576467?

The interventions under investigation include: Enhanced Usual Care (EUC) (BEHAVIORAL), MBCT-Telephone (BEHAVIORAL), MBCT-Video (BEHAVIORAL).

Who is sponsoring clinical trial NCT05576467?

This trial is sponsored by Amanda Shallcross, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05576467 being conducted?

This trial has 3 study locations across New York, North Carolina, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Migraine

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.